CARM1 and cancer: Originally identified as a co-activator of steroid hormone receptor-mediated transcription, CARM1 has been shown to interact with several nuclear receptors including the estrogen and androgen receptors, and it may mediate oncogenic effects in cancers driven by these pathways17.